DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Overview Fund Activity
Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

183 hedge funds and large institutions have $1.61B invested in Dicerna Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 55 increasing their positions, 67 reducing their positions, and 22 closing their positions.

Holders
183
Holders Change
+10
Holders Change %
+5.78%
% of All Funds
3.22%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
34
Increased
55
Reduced
67
Closed
22
Calls
$5.27M
Puts
$8.48M
Net Calls
-$3.21M
Net Calls Change
+$70K

Top Buyers

1
MC
1
Maverick Capital
Texas
$34.6M
2
PCH
2
Polar Capital Holdings
United Kingdom
$27.7M
3
Morgan Stanley
3
Morgan Stanley
New York
$21.9M
4
AG
4
Artal Group
Luxembourg
$20.5M
5
BM
5
Bridger Management
New York
$15.1M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$15.5M
2
Citadel Advisors
2
Citadel Advisors
Florida
$12.5M
3
UBS Group
3
UBS Group
Switzerland
$35.3M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$3.78M
5
CCM
5
Camber Capital Management
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
RI
1
RTW Investments
New York
$191M 7,463,291 +209,434 +3%
BlackRock
2
BlackRock
New York
$156M 6,117,166 +82,437 +1%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$110M 4,320,900 +3,277 +0.1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$91.2M 3,567,645 +211,926 +6%
BCLSI
5
Bain Capital Life Sciences Investors
Massachusetts
$78.8M 3,080,237 – –
State Street
6
State Street
Massachusetts
$77.9M 3,045,557 +225,458 +8%
WP
7
Woodline Partners
California
$45.4M 1,777,000 +418,204 +31%
ACM
8
Aquilo Capital Management
California
$43.6M 1,705,392 +350,000 +26%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$43.3M 1,693,182 -379,035 -18%
Loomis, Sayles & Company
10
Loomis, Sayles & Company
Massachusetts
$40.7M 1,591,568 +220,296 +16%
UBS Group
11
UBS Group
Switzerland
$35.3M 1,378,623 -821,864 -37%
EAM
12
Eagle Asset Management
Florida
$34.7M 1,346,426 -184,226 -12%
MC
13
Maverick Capital
Texas
$34.6M 1,352,802 +1,352,802 New
CS
14
Candriam SCA
Luxembourg
$29.8M 1,408,993 – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$28.7M 1,122,506 +89,668 +9%
PCH
16
Polar Capital Holdings
United Kingdom
$27.7M 1,084,813 +1,084,813 New
Goldman Sachs
17
Goldman Sachs
New York
$27.3M 1,068,569 -10,304 -1%
JPMorgan Chase & Co
18
JPMorgan Chase & Co
New York
$26.4M 1,033,624 +234,315 +29%
Morgan Stanley
19
Morgan Stanley
New York
$21.9M 856,610 +801,509 +1,455%
PA
20
Perceptive Advisors
New York
$20.5M 800,000 – –
AG
21
Artal Group
Luxembourg
$20.5M 800,000 +800,000 New
Northern Trust
22
Northern Trust
Illinois
$19.7M 771,469 -62,427 -7%
Fidelity Investments
23
Fidelity Investments
Massachusetts
$15.8M 618,712 -103,800 -14%
Point72 Asset Management
24
Point72 Asset Management
Connecticut
$15.5M 606,439 -1,759,786 -74%
BM
25
Bridger Management
New York
$15.1M 588,910 +588,910 New
1
2 3 4 5